Amicus Therapeutics announced FDA approval and launch of treatment for Pompe disease
On Sept. 28, 2023, Amicus Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved Pombilitiï¾™…
On Sept. 28, 2023, Amicus Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved Pombilitiï¾™…
On Sept. 27, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that new diagnoses of…
On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…
On Sept. 26, 2023, the U.S. National Science Foundation (NSF) announced it had invested $26.7 million in 18…
On Sept. 26, 2023, the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department…
On Sep. 26, 2023, the U.S. Department of Agriculture (USDA) announced they had reviewed a hemp plant modified…
On Sept. 25, 2023, the Washington State Department of Health confirmed the presence of West Nile virus in…
On Sept. 25, 2023, researchers at the University of California, Berkeley reported that engineered viruses also can generate…
On Sept. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced the recipients of 13…
On Sept. 15, 2023, researchers at the National Institute of Allergy and Infectious Diseases announced they had begun…
On Sept. 15, 2023, a Northwestern Medicine study challenges a common belief in what triggers Parkinsonï¾’s disease. Degeneration…
On Sept. 14, 2023, Northwestern University announcealberta_innovates_logo.pngd it had been awarded $50 million over five years from the…
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
On Sept. 10, 2023, the White House announced $240 million in additional investment through the Advanced Research Projects…
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
On Sept. 6, 2023, the U.S. Department of Agriculture’s Agricultural Research Service and NC State University’s College of…
On Sept. 1, 2023, the U.S. Centers for Disease Control and Prevention (CDC) awarded $279 million to 49…
On Sept. 1, 2023, the North Dakota Development Fund, an investment vehicle for the North Dakota Department of…
On Aug. 31, 2023, study results published in JAMA found that psilocybin treatment was associated with a clinically…
On Aug. 30, 2023, Emergent BioSolutions announced NARCANï¾® Naloxone HCl Nasal Spray 4 mg would be available on…
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Aug. 29, 2023, the COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual…
On Aug. 28, 2023, in a study of 152 deceased athletes less than 30 years old who were…
On Aug. 25. 2023, the Advisory Committee on Immunization Practices (ACIP) published new recommendations by the Advisory Committee…
On Aug. 24, 2023, the U.S. Food and Drug Administration approved Sandoz’s Tyruko (natalizumab-sztn), the first biosimilar to…
On Aug. 24, 2023, researchers at City of Hope announced were awarded $32.3 million from the California Institute…
On Aug. 23, 2023, an international research team announced they had generated the first truly complete sequence of…
On Aug. 23, 2023, the CDC announced it had detected a new SARS-CoV-2 variant labeled BA.2.86. CDC was…
On Aug. 23. 2023, researchers co-led by University of California, Santa Cruz Assistant Professor of Biomolecular Engineering Karen…